# The Role of Sugammadex in Posotoperative Urinary Retention in Patients Undergoing Pelvic Floor Reconstructive Procedures

> **NCT05664633** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **West Virginia University**

## Conditions studied

- Postoperative Urinary Retention

## Interventions

- **DRUG:** Sugammadex

## Key facts

- **NCT ID:** NCT05664633
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-08
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** technical aspects - unable to continue with the study. Investigator left institution. No patients enrolled.
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05664633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05664633, "The Role of Sugammadex in Posotoperative Urinary Retention in Patients Undergoing Pelvic Floor Reconstructive Procedures". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05664633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*